Ananym Capital Management LP Has $21.04 Million Position in Sotera Health Company $SHC

Ananym Capital Management LP trimmed its holdings in Sotera Health Company (NASDAQ:SHC) by 15.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,192,833 shares of the company’s stock after selling 217,684 shares during the quarter. Sotera Health comprises 8.7% of Ananym Capital Management LP’s portfolio, making the stock its 6th largest holding. Ananym Capital Management LP owned about 0.42% of Sotera Health worth $21,042,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in SHC. Sculptor Capital LP grew its holdings in Sotera Health by 57.4% in the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock worth $370,440,000 after buying an additional 7,658,200 shares in the last quarter. Sachem Head Capital Management LP grew its holdings in Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after buying an additional 3,735,000 shares in the last quarter. Vanguard Group Inc. grew its holdings in Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after buying an additional 2,756,583 shares in the last quarter. AQR Capital Management LLC grew its holdings in Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after buying an additional 2,644,831 shares in the last quarter. Finally, Norges Bank bought a new position in Sotera Health in the 4th quarter worth approximately $45,278,000. 91.03% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.36% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SHC. Piper Sandler reissued an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays decreased their price objective on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings downgraded Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Finally, Citigroup upped their target price on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.29.

Sotera Health Stock Performance

SHC opened at $15.46 on Thursday. The company has a market capitalization of $4.41 billion, a price-to-earnings ratio of 37.71 and a beta of 1.79. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health Company has a 1-year low of $10.84 and a 1-year high of $19.85. The business has a 50 day moving average price of $15.67 and a two-hundred day moving average price of $16.35.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.